CONTAC Allergy

Manufacturer: Vespyr Brands LLC
Effective date: 2026-05-01
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-06-01 01:56:14

Label at a glance#

ProductCONTAC Allergy

Active ingredientLORATADINE

Label structure10 sections

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-855-874-0970

Websitewww.contac.com

www.contac.com

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)

Loratadine USP 10 mg

OTC - PURPOSE SECTION

Purpose

Antihistamine

INDICATIONS & USAGE SECTION

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
• runny nose • itchy, watery eyes
• sneezing • itching of the nose or throat

WARNINGS SECTION

Warnings

OTC - DO NOT USE SECTION

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

OTC - ASK DOCTOR SECTION

Ask a doctor before useif you have liver or kidney disease. Your doctor should determine if you need a different dose.

OTC - WHEN USING SECTION

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

OTC - STOP USE SECTION

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DOSAGE & ADMINISTRATION SECTION

Directions

adults and children 6 years and over	1 tablet daily; not more than 1 tablet in 24 hours
children under 6 years of age	ask a doctor
consumers with liver or kidney disease	ask a doctor

Other information

SPL UNCLASSIFIED SECTION

•Tamper-evident: do not use if foil seal under cap, printed with “SEALED for YOUR PROTECTION” is missing, open or broken
•store at 20° to 25°C (68° to 77°F)
•protect from excessive moisture

INACTIVE INGREDIENT SECTION

Inactive ingredients
lactose monohydrate, magnesium stearate, pregelatinized starch (maize), sodium starch glycolate.

OTC - QUESTIONS SECTION

Questions or comments?
call 1-855-874-0970 Mon-Fri 8am - 5pm EST

SPL UNCLASSIFIED SECTION

DISTRIBUTED BY:

Vespyr Brands ^®, LLC.

East Windsor, NJ 08520

Contac ^® is a registered trademark of Vespyr Brands ^®, LLC.

www.contac.com

Made in India

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 71179-010-85

CONTAC _®

ALLERGY

Non-Drowsy*

Laratadine Tablets USP 10 mg

Antihistamine

INDOOR & OUTDOOR ALLERGIES

24 HR RELIEF

Relief of:

•Sneezing • Itchy, Watery Eyes

•Runny Nose • Itchy Throat or Nose

150 label

300 label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
311372	loratadine 10 MG 24HR Oral Tablet	PSN	2
311372	loratadine 10 MG Oral Tablet	SCD	2
311372	loratadine 10 MG 24 HR Oral Tablet	SY	2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71179-010-85	CONTAC Allergy	1 in 1 CARTON	TABLET	1	2
71179-010-85	CONTAC Allergy	150 in 1 BOTTLE	TABLET	150	2
71179-010-97	CONTAC Allergy	150 in 1 BOTTLE	TABLET	150	2
71179-010-97	CONTAC Allergy	2 in 1 CARTON	TABLET	2	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

CONTAC Allergy
Loratadine
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A
STARCH, CORN
LACTOSE MONOHYDRATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
71179-010	71179-010-85, 71179-010-97

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
MAGNESIUM STEARATE	70097M6I30	IACT
SODIUM STARCH GLYCOLATE TYPE A	H8AV0SQX4D	IACT
STARCH, CORN	O8232NY3SJ	IACT
LORATADINE	7AJO3BO7QN	ACTIB
LACTOSE MONOHYDRATE	EWQ57Q8I5X	IACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
Version	Effective date	Source	Hydrated
1	2025-12-09	monthly-update	2026-06-03 17:56:00

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A208314-001	LORATADINE	LORATADINE	10MG	TABLET / ORAL			2018-04-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A208314-001	LORATADINE	10MG	TABLET / ORAL	2018-04-16	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CONTAC Allergy	LORATADINE	Vespyr Brands LLC	4587a61d-139e-2a5b-e063-6394a90a1311	2026-05-01	Warnings	Exact identifier ndc (package): 71179-010-97 ndc (package): 71179-010-85 ndc (product): 71179-010 ndc11 (package): 71179001085 ndc11 (package): 71179001097 spl id: 5143484f-5600-3b37-e063-6394a90a3cb9 spl set id: 4587a61d-139e-2a5b-e063-6394a90a1311

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.